Regulations.gov document
Letter from Eli Lilly and Co. (Hogan Lovells) to FDA DDM
Other · FDA-2017-E-5106 · posted Feb 12, 2019
Key facts
| Document ID | FDA-2017-E-5106-0008 |
|---|---|
| Title | Letter from Eli Lilly and Co. (Hogan Lovells) to FDA DDM |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2017-E-5106 |
| Posted | Feb 12, 2019 |
| Comment period opens | Feb 12, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: